<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02455778</url>
  </required_header>
  <id_info>
    <org_study_id>Cinnamon 2010</org_study_id>
    <nct_id>NCT02455778</nct_id>
  </id_info>
  <brief_title>Effect of Oral Cinnamon Intervention in Metabolic Syndrome</brief_title>
  <official_title>Effect of Intervention With Oral Cinnamon on Metabolic Profile and Body Composition of Asian Indians With Metabolic Syndrome in North India: A 16 Week Double Blind Placebo Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diabetes Foundation, India</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institute of Home Economics, India</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Diabetes Foundation, India</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This double blind placebo control study with supplementation of oral Cinnamon is being
      conducted to test the hypothesis that in subjects with Metabolic Syndrome oral cinnamon may
      lead to improvement in body composition and metabolic parameters.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fasting Blood Glucose</measure>
    <time_frame>baseline to 4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>HbA1c</measure>
    <time_frame>baseline to 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipid profile</measure>
    <time_frame>baseline to 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body fat percentage</measure>
    <time_frame>baseline to 4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>baseline to 4 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">103</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Cinnamon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 grams of oral cinnamon per day in form of capsules (6) along with standard diet and exercise protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2.5 grams of wheat flour per day in form of capsules ( 6) along with standard diet and exercise protocol</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cinnamon</intervention_name>
    <arm_group_label>Cinnamon</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects aged between 25 -65 years

          2. Subjects identified with any three of following:

               1. Fasting blood glucose ≥100 mg/ dL

               2. Waist circumference ≥ 90 cm ( males) ≥ 80 cm (females)

               3. Triglycerides ≥ 150 mg/dL

               4. High density lipoprotein cholesterol ≤ 40 mg/dL ( in males) , ≤ 50 mg/dL (in
                  females)

               5. Blood pressure Systolic BP ≥ 130 mm Hg

               6. Diastolic BP ≥ 85 mm Hg

          3. Subjects who were willing to participate in the study.

          4. Subjects, if on medication for high blood pressure were stable and there was no change
             in the dosage for the past 3 months.

        Exclusion Criteria:

          1. Subjects suffering from other chronic diseases and metabolic complications such as
             cardiovascular disease, diabetes, renal disease, myocardial infarction and other
             endocrine disorders.

          2. Subjects who were allergic to wheat flour and cinnamon.

          3. Subjects who were on medication of anti dyslipidemic or hypoglycemic drugs.

          4. Subjects who had undergone bypass procedure.

          5. Subjects suffering from any debilitating disease such as tuberculosis, HIV etc.

          6. Subjects suffering from uncontrolled hypothyroidism/ hyperthyroidism

          7. Pregnant and lactating mothers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology</name>
      <address>
        <city>Delhi</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2015</study_first_submitted>
  <study_first_submitted_qc>May 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2015</study_first_posted>
  <last_update_submitted>May 28, 2015</last_update_submitted>
  <last_update_submitted_qc>May 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Diabetes Foundation, India</investigator_affiliation>
    <investigator_full_name>Dr Anoop Misra</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

